Certara, a leading provider of biosimulation and drug development solutions, is headquartered in the United States. Founded in 2008, the company has established itself as a pivotal player in the pharmaceutical and biotechnology industries, focusing on enhancing drug development processes through advanced modelling and simulation technologies. With a strong presence in North America, Europe, and Asia, Certara offers a range of core services, including pharmacokinetics, pharmacodynamics, and regulatory submission support. Their unique approach integrates cutting-edge software and expert consulting, enabling clients to make informed decisions throughout the drug development lifecycle. Recognised for its innovative contributions, Certara has achieved significant milestones, positioning itself as a trusted partner for biopharmaceutical companies aiming to streamline their research and development efforts.
How does Certara's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Certara's score of 61 is higher than 77% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Certara, headquartered in the United States, reported total carbon emissions of approximately 7,073,000 kg CO2e. This figure includes 160,670 kg CO2e from Scope 1 emissions, primarily from fugitive emissions, and 796,480 kg CO2e from Scope 2 emissions, with the majority stemming from purchased electricity (766,340 kg CO2e). The most significant portion of their emissions comes from Scope 3, amounting to about 6,145,990 kg CO2e. Comparatively, in 2023, Certara's total emissions were about 9,010,770 kg CO2e, with Scope 1 emissions at 363,340 kg CO2e, Scope 2 emissions at 816,410 kg CO2e, and Scope 3 emissions reaching approximately 7,765,850 kg CO2e. This indicates a reduction in total emissions from 2023 to 2024. Certara has set ambitious near-term targets to reduce its Scope 1 and Scope 2 emissions to near zero by 2025. These commitments reflect the company's dedication to addressing its carbon footprint and contributing to climate action. Certara is currently committed to these reduction targets but has not yet established a net-zero commitment. The emissions data and reduction initiatives are sourced directly from Certara, Inc., with no data cascaded from a parent or related organization.
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 441,770 | 000,000 | 000,000 | 
| Scope 2 | 1,127,010 | 000,000 | 000,000 | 
| Scope 3 | - | 0,000,000 | 0,000,000 | 
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Certara has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
